These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33364982)

  • 1. Tumor Necrosis Factor-α Variations in Patients With Major Depressive Disorder Before and After Antidepressant Treatment.
    Yao L; Pan L; Qian M; Sun W; Gu C; Chen L; Tang X; Hu Y; Xu L; Wei Y; Hui L; Liu X; Wang J; Zhang T
    Front Psychiatry; 2020; 11():518837. PubMed ID: 33364982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum cytokines-based biomarkers in the diagnosis and monitoring of therapeutic response in patients with major depressive disorder.
    Xu Y; Liang J; Sun Y; Zhang Y; Shan F; Ge J; Xia Q
    Int Immunopharmacol; 2023 May; 118():110108. PubMed ID: 37004349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melancholic and atypical major depression--connection between cytokines, psychopathology and treatment.
    Dunjic-Kostic B; Ivkovic M; Radonjic NV; Petronijevic ND; Pantovic M; Damjanovic A; Poznanovic ST; Jovanovic A; Nikolic T; Jasovic-Gasic M
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():1-6. PubMed ID: 23200828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the serum levels of inflammatory cytokines in antidepressant drug-naïve patients with major depression.
    Zou W; Feng R; Yang Y
    PLoS One; 2018; 13(6):e0197267. PubMed ID: 29856741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder.
    Tuglu C; Kara SH; Caliyurt O; Vardar E; Abay E
    Psychopharmacology (Berl); 2003 Dec; 170(4):429-33. PubMed ID: 12955291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SIGIRR and TNFAIP3 Are Differentially Expressed in Both PBMC and TNF-α Secreting Cells of Patients With Major Depressive Disorder.
    Lin CC; Huang TL
    Front Psychiatry; 2021; 12():698257. PubMed ID: 34393859
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response.
    Myung W; Lim SW; Woo HI; Park JH; Shim S; Lee SY; Kim DK
    Psychiatry Investig; 2016 Nov; 13(6):644-651. PubMed ID: 27909456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study on cytokine levels in medication-naïve adolescents with first-episode major depressive disorder.
    Lee H; Song M; Lee J; Kim JB; Lee MS
    J Affect Disord; 2020 Apr; 266():57-62. PubMed ID: 32056928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon and anti-TNF therapies differentially modulate amygdala reactivity which predicts associated bidirectional changes in depressive symptoms.
    Davies KA; Cooper E; Voon V; Tibble J; Cercignani M; Harrison NA
    Mol Psychiatry; 2021 Sep; 26(9):5150-5160. PubMed ID: 32457424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated TNIP3 mRNA Expression in TNF-α-Secreting Cells from Patients with Major Depressive Disorder.
    Huang KW; Wu MK; Hung YY
    Neuroimmunomodulation; 2019; 26(3):153-158. PubMed ID: 31307045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis.
    Liu JJ; Wei YB; Strawbridge R; Bao Y; Chang S; Shi L; Que J; Gadad BS; Trivedi MH; Kelsoe JR; Lu L
    Mol Psychiatry; 2020 Feb; 25(2):339-350. PubMed ID: 31427752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls.
    Kurita H; Maeshima H; Kida S; Matsuzaka H; Shimano T; Nakano Y; Baba H; Suzuki T; Arai H
    J Affect Disord; 2013 Apr; 146(2):205-12. PubMed ID: 23102506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Mirtazapine Treatment on Serum Levels of Brain-Derived Neurotrophic Factor and Tumor Necrosis Factor-α in Patients of Major Depressive Disorder with Severe Depression.
    Gupta R; Gupta K; Tripathi AK; Bhatia MS; Gupta LK
    Pharmacology; 2016; 97(3-4):184-8. PubMed ID: 26854819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study.
    Abbasi SH; Hosseini F; Modabbernia A; Ashrafi M; Akhondzadeh S
    J Affect Disord; 2012 Dec; 141(2-3):308-14. PubMed ID: 22516310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenetic and Therapeutic Applications of Tumor Necrosis Factor-α (TNF-α) in Major Depressive Disorder: A Systematic Review.
    Ma K; Zhang H; Baloch Z
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of serum cortisol level with severity of depression and improvement in newly diagnosed patients with major depressive disorder in Jimma medical center, Southwest Ethiopia.
    Alenko A; Markos Y; Fikru C; Tadesse E; Gedefaw L
    PLoS One; 2020; 15(10):e0240668. PubMed ID: 33064754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Randomized Clinical Trial Comparing Two Treatment Strategies, Evaluating the Meaningfulness of HAM-D Rating Scale in Patients With Major Depressive Disorder.
    Asghar J; Tabasam M; Althobaiti MM; Adnan Ashour A; Aleid MA; Ibrahim Khalaf O; Aldhyani THH
    Front Psychiatry; 2022; 13():873693. PubMed ID: 35722557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered serum interleukin-7 and interleukin-10 are associated with drug-free major depressive disorder.
    Anjum S; Qusar MMAS; Shahriar M; Islam SMA; Bhuiyan MA; Islam MR
    Ther Adv Psychopharmacol; 2020; 10():2045125320916655. PubMed ID: 32435448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.